A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ...

Traws Pharma, Inc. (NASDAQ: TRAW) has released its financial results for the year ending December 31, 2024, alongside ...

Federal budget cuts this week have undercut research at the University of Minnesota that was closing in on a better COVID-19 antiviral therapy and first-ever treatments for Ebola and other threatening ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

Emerging data suggest that antiviral therapy in the third trimester can prevent immunoprophylaxis failure. To minimize fetal exposure to antiviral agents, antiviral therapy during pregnancy should ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting ...

CBA therapy of HIV (and possibly other pathogens ... There is a high demand, therefore, for new antiviral lead compounds and novel therapeutic concepts. In this Review, an original therapeutic ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

In parallel, these gene functions are outstanding targets for the development of antiviral therapies against common ... He is currently an Associate Scientist at the Vaccine and Gene Therapy Institute ...